These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 35726096)

  • 1. Morphological basis of Parkinson disease-associated cognitive impairment: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Aug; 129(8):977-999. PubMed ID: 35726096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of cognitive impairment in Parkinson's disease.
    Jellinger KA
    Expert Rev Neurother; 2012 Dec; 12(12):1451-66. PubMed ID: 23237352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
    Mak E; Su L; Williams GB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.
    Li CH; Chen TF; Peng PL; Lin CH
    J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.
    Jellinger KA
    J Neural Transm (Vienna); 2013 Jan; 120(1):157-67. PubMed ID: 22350538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia.
    Jellinger KA
    Front Neurol Neurosci; 2009; 24():114-125. PubMed ID: 19182469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease.
    Chung SJ; Kim YJ; Jung JH; Lee HS; Ye BS; Sohn YH; Jeong Y; Lee PH
    Neurology; 2022 May; 98(18):e1846-e1856. PubMed ID: 35190467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease.
    Goldman JG; Litvan I
    Minerva Med; 2011 Dec; 102(6):441-59. PubMed ID: 22193376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topography of cortical thinning in the Lewy body diseases.
    Ye R; Touroutoglou A; Brickhouse M; Katz S; Growdon JH; Johnson KA; Dickerson BC; Gomperts SN
    Neuroimage Clin; 2020; 26():102196. PubMed ID: 32059167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive decline in Parkinson disease.
    Aarsland D; Creese B; Politis M; Chaudhuri KR; Ffytche DH; Weintraub D; Ballard C
    Nat Rev Neurol; 2017 Apr; 13(4):217-231. PubMed ID: 28257128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.